BENNETT C FRANK
EVP, Chief Scientific Officer · 6 filings · Latest: Mar 3, 2026
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Mar 3, 2026 | Sale | $79.23 | 85,089 | $6.7M | 80,554 | |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Mar 3, 2026 | Option Exercise | $53.73 | 65,089 | $3.5M | 165,643 | |
IONS | BENNETT C FRANK | — | Mar 3, 2026 | Proposed Sale | $82.93 | 85,089 | $7.1M | — | Mar 3 10:52 PM 144/A |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 2, 2026 | Option Exercise | $53.73 | 65,089 | $3.5M | 96,756 | |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 2, 2026 | Sale | $82.93 | 85,089 | $7.1M | 80,293 | |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 30, 2026 | Sale | $82.95 | 5,885 | $488.1K | 100,293 | |
IONS | BENNETT C FRANK | — | Feb 2, 2026 | Proposed Sale | $82.93 | 85,089 | $7.1M | — | |
IONS | BENNETT C FRANK | — | Jan 30, 2026 | Proposed Sale | $82.91 | 5,885 | $487.9K | — | |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 16, 2026 | Sale | $75.15 | 8,977 | $674.6K | 94,757 | |
IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 15, 2026 | Option Exercise | $0.00 | 21,055 | — | 103,734 | |
IONS | BENNETT C FRANK | — | Jan 16, 2026 | Proposed Sale | $76.22 | 8,977 | $684.3K | — | |
IONS | BENNETT C FRANK | — | Sep 3, 2025 | Proposed Sale | $60.86 | 51,800 | $3.2M | — | |
IONS | BENNETT C FRANK | — | Aug 18, 2025 | Proposed Sale | $43.98 | 16,000 | $703.6K | — | |
IONS | BENNETT C FRANK | — | Jan 31, 2025 | Proposed Sale | $35.00 | 1,803 | $63.1K | — | |
IONS | BENNETT C FRANK | — | Jan 16, 2025 | Proposed Sale | $32.70 | 6,752 | $220.8K | — | |
IONS | BENNETT C FRANK | — | Feb 1, 2024 | Proposed Sale | $49.52 | 1,885 | $93.3K | — | Sep 5 1:27 AM 144/A |